Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma [Phase 2]
Phase 2 trial update for chidamide in patients with relapse or refractory diffuse large B-cell lymphoma and follicular lymphoma is ongoing w…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 trial comparing Inotuzumab Ozogamicin plus Rituximab vs investigator's choice in follicular lymphoma was terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating induction with oral fludarabine, mitoxantrone, and rituximab followed by rituximab maintenance in follicular B-cell…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab plus GM-CSF in newly diagnosed follicular lymphoma has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
This trial update reports on PET/CT imaging protocol optimization using optimized F18-FDG dosing to minimize radiation exposure while improv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas [Phase 1]
Phase I study of alisertib combined with R-EPOCH for myc-positive aggressive B-cell lymphomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
This is a Phase 1 clinical trial update for the anti-CD20 antibody ofatumumab in Japanese patients with CD20-positive follicular lymphoma or…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating low-dose radiation therapy for follicular lymphoma and marginal zone lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
This clinical trial update reports on an observational study of Rituxan/MabThera (rituximab) plus chemotherapy as first-line treatment for d…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating BCD-020 for indolent non-Hodgkin lymphomas has completed, assessing safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
This completed trial evaluated factors associated with hepatitis B reactivation in patients with diffuse large B-cell lymphoma or follicular…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Safety Study of SGN-CD19A for B-Cell Lymphoma [Phase 1]
Phase 1 safety study of SGN-CD19A in various B-cell lymphomas has completed; the update summarizes safety results across multiple indication…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) [Phase 2]
A Phase 2 trial evaluating venetoclax with BR versus BR or venetoclax with rituximab in relapsed/refractory follicular lymphoma; results pos…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the combination of pegfilgrastim and rituximab in patients with untreated, relapsed, or refractory follicu…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: A Phase I/II Study of Intratumoral Injection of SD-101 [Phase 1, Phase 2]
Phase I/II trial investigating intratumoral SD-101 for various B-cell lymphomas; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating temsirolimus with bendamustine and rituximab in relapsed follicular lymphoma or mantle cell lymphoma has been com…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial of Ibrutinib (PCI-32765) in patients with refractory follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. [Phase 3]
A Phase 3 trial comparing first-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphomas with maintenance therapy; the s…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype [Phase 1]
A Phase 1 clinical trial evaluating vaccination with tumor-derived immunoglobulin idiotype for follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines [Phase 1]
A Phase 1 trial evaluated a tumor-derived immunoglobulin idiotype antigen vaccine for follicular lymphoma. The trial status indicates comple…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies [Phase 2]
A Phase 2 trial evaluating a combination of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with previously treated lymph…
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of combining veltuzumab with fractionated Y-90 epratuzumab radioimmunotherapy in follicular lymphoma; study terminated with …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma [Phase 2]
This Phase 2 clinical trial update evaluates whether rituximab can help achieve PCR-negative leukapheresis products in patients with relapse…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a multi-modality approach combining Yttrium-90 ibritumomab tiuxetan, fludarabine, radiation therapy, and d…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim [Phase 1]
Open-label Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Aurixim in lymphoma patients; study compl…